1. Unravelling the mysteries: a reflection on rare neurological diseases

   • Massimiliano Filosto
   • Michelangelo Mancuso
   • Alessandro Padovani

   Editorial 02 February 2024 Pages: 833 - 835

2. SARS-CoV-2’s brain impact: revealing cortical and cerebellar differences via cluster analysis in COVID-19 recovered patients

   • Angel Omar Romero-Molina
   • Gabriel Ramirez-Garcia
   • Juan Fernandez-Ruiz

   COVID-19 04 January 2024 Pages: 837 - 848

   

3. COVID-19-associated serum and cerebrospinal fluid cytokines in post- versus para-infectious SARS-CoV-2-related Guillain–Barré syndrome

   • Federico Massa
   • Tiziana Vigo
   • Luana Benedetti

   COVID-19 03 January 2024 Pages: 849 - 859

   

4. The place of Free Will: the freedom of the prisoner

   • Paolo F. Nichelli
   • Jordan Grafman

   Review Article 23 October 2023 Pages: 861 - 871

   

5. Progress in direct reprogramming of dopaminergic cell replacement therapy

   • Yuan Yuan Zheng
   • Hui Xu
   • Yue Si Wang

   Review Article 10 November 2023 Pages: 873 - 881

   

6. Transcranial direct current stimulation for global cognition in Alzheimer’s disease: a systemic review and meta-analysis

   • Xin Wang
   • Lu Tian

   Review Article 02 November 2023 Pages: 883 - 895

   

7. The effects of rTMS on motor recovery after stroke: a systematic review of fMRI studies

   • Zhiqing Tang
   • Tianhao Liu
   • Hao Zhang

   Review Article 25 October 2023 Pages: 897 - 909

   

8. Theta-burst stimulation as a therapeutic tool in neurological pathology: a systematic review

   • Nicoleta Jemna
   • Ana Calina Zdrenghea
   • Fior Dafin Muresanu

   Review Article 26 October 2023 Pages: 911 - 940

   

9. Pharmacological treatment of Tourette’s syndrome: from the past to the future

   • Hao Gong
   • Xiangyu Du
   • Yaowu Du

   Review Article 14 November 2023 Pages: 941 - 962

   

10. Non-pharmacological treatment of hereditary spastic paraplegia: a systematic review

    • Simona Maccora
    • Angelo Torrente
    • Filippo Brighina

    Review Article Open access 16 November 2023 Pages: 963 - 976

    

11. Performance-based outcome measures of upper extremity in virtual reality and telerehabilitation: a systematic review

    • Jie Hao
    • Yanfei Li
    • Yuqi Pu

    Review Article 31 October 2023 Pages: 977 - 986

    

12. Neurological complications due to copper deficiency in the context of Wilson disease treatment: a case report with long-term follow-up and review of the literature

    • Danilo Tornabene
    • Paola Bini
    • Luca Diamanti

    Review Article Open access 18 October 2023 Pages: 987 - 996

    

13. Subarachnoid hemorrhage due to pituitary adenoma apoplexy—case report and review of the literature

    • Yesim Yildiz
    • Arno Lauber
    • Isabel Charlotte Hostettler

    Review Article 23 October 2023 Pages: 997 - 1005

    

14. Child-to-adult transition: a survey of current practices within the European Reference Network for Rare Neurological Diseases (ERN-RND)

    • Lorenzo Nanetti
    • Mary Kearney
    • on Behalf of ERN-RND Working Group for Management of Transition

    Original Article 19 October 2023 Pages: 1007 - 1016

    

15. Is headache a risk factor for dementia? A systematic review and meta-analysis

    • Aurora Cermelli
    • Fausto Roveta
    • Innocenzo Rainero

    Original Article Open access 18 September 2023 Pages: 1017 - 1030

    

16. The role of plasma neurofilament light chain and glial fibrillary acidic protein in subjective cognitive decline and mild cognitive impairment

    • Salvatore Mazzeo
    • Assunta Ingannato
    • Valentina Bessi

    Original Article Open access 19 September 2023 Pages: 1031 - 1039

    

17. Association of APOE gene with longitudinal changes of CSF amyloid beta and tau levels in Alzheimer’s disease: racial differences

    • Chun Xu
    • Danqing Xiao
    • The Alzheimer and Disease Neuroimaging Initiative

    Original Article 28 September 2023 Pages: 1041 - 1050

    

18. Parkinson-ALS with a novel MAPT variant

    • Camilla Ferrari
    • Assunta Ingannato
    • Benedetta Nacmias

    Original Article Open access 20 September 2023 Pages: 1051 - 1055

    

19. Sensory disturbances in Creutzfeldt-Jakob disease

    • Shmuel Appel
    • Yael Cohen
    • Esther Kahana

    Original Article 13 October 2023 Pages: 1057 - 1062

20. Development of the Digital Inclusion Questionnaire (DIQUEST) in Parkinson’s Disease

    • Vincenzo Canoro
    • Marina Picillo
    • Roberto Erro

    Original Article Open access 16 October 2023 Pages: 1063 - 1069

    

21. Sexual dysfunction in a sample of Egyptian patients with Parkinson’s disease

    • Heba Assem Deraz Abdelhalim Deraz
    • Hanan Abdalla Hassan Amer
    • Ahmed Dahshan

    Original Article Open access 02 October 2023 Pages: 1071 - 1077

    

22. Validity, diagnostics and feasibility of the Italian version of the Montreal Cognitive Assessment (MoCA) in Huntington’s disease

    • Edoardo Nicolò Aiello
    • Federica Solca
    • Barbara Poletti

    Original Article 28 September 2023 Pages: 1079 - 1086

23. Frontotemporal-spectrum disorders and functional independence in non-demented ALS patients

    • Edoardo Nicolò Aiello
    • Federica Solca
    • Barbara Poletti

    Original Article Open access 29 September 2023 Pages: 1087 - 1095

24. Do stroke services still show sex differences? A multicenter study

    • Nevine El Nahas
    • Hossam Shokri
    • Valeria Caso

    Original Article Open access 18 September 2023 Pages: 1097 - 1108

25. Five-year stroke prognosis. Influence of post-stroke delirium and post-stroke dementia on mortality and disability (Research Study – Part of the PROPOLIS Study)

    • Jakub Droś
    • Natalia Segiet
    • Aleksandra Klimkowicz-Mrowiec

    Original Article Open access 18 October 2023 Pages: 1109 - 1119

    

26. Current status and value of testing antiphospholipid antibody in patients with acute ischemic stroke: a retrospective single-center study in China

    • Qiqi Wang
    • Guangsong Han
    • Jun Ni

    Original Article 14 September 2023 Pages: 1121 - 1128

27. Reperfusion strategies in stroke with medium-to-distal vessel occlusion: a prospective observational study

    • Federica Rizzo
    • Michele Romoli
    • Andrea Zini

    Original Article 06 October 2023 Pages: 1129 - 1134

28. The impact of perfusion computed tomography on the diagnosis and outcome of delayed cerebral ischemia after subarachnoid hemorrhage

    • Mohamed Seyour
    • Michele Salvagno
    • Elisa Gouvea Bogossian

    Original Article 13 October 2023 Pages: 1135 - 1144

    

29. User appraisal of a booklet for advance care planning in multiple sclerosis: a multicenter, qualitative Italian study

    • Andrea Giordano
    • Ludovica De Panfilis
    • Alessandra Solari

    Original Article Open access 10 October 2023 Pages: 1145 - 1154

    

30. The administration of the paper and electronic versions of the Manual Ability Measure-36 (MAM-36) and Fatigue Severity Scale (FSS) is equivalent in people with multiple sclerosis

    • Andrea Tacchino
    • Rachele Di Giovanni
    • Claudio Marcello Solaro

    Original Article 12 October 2023 Pages: 1155 - 1162

31. Retinal clues for selective neuronal loss in multiple sclerosis

    • Vedat Cilingir
    • Erbil Seven

    Original Article 14 October 2023 Pages: 1163 - 1171

    

32. Risk of central nervous system demyelinating attack or optic neuritis recurrence after pediatric optic neuritis in Korea

    • Yeji Moon
    • Kyung-Ah Park
    • Jae Ho Jung

    Original Article 19 October 2023 Pages: 1173 - 1183

    

33. Profiling migraine patients according to clinical and psychophysical characteristics: clinical validity of distinct migraine clusters

    • Stefano Di Antonio
    • Lars Arendt-Nielsen
    • Matteo Castaldo

    Original Article Open access 13 October 2023 Pages: 1185 - 1200

    

34. Working memory during spontaneous migraine attacks: an fMRI study

    • Amparo Ruiz-Tagle
    • Patrícia Figueiredo
    • Raquel Gil-Gouveia

    Original Article Open access 17 October 2023 Pages: 1201 - 1208

    

35. Phenotypes and clinical subgroups in vestibular migraine: a cross-sectional study with cluster analysis

    • Roberto Teggi
    • Bruno Colombo
    • Massimo Filippi

    Original Article 16 October 2023 Pages: 1209 - 1216

36. Translating the Cluster Headache Quality of Life Questionnaire (CHQ) from English to Dutch with the TRAPD method

    • Willemijn C. Naber
    • Roemer B. Brandt
    • Rolf Fronczek

    Original Article Open access 06 October 2023 Pages: 1217 - 1224

    

37. Marked neuropsychiatric involvement and dysmorphic features in nemaline myopathy

    • Paulo Ribeiro Nóbrega
    • Jorge Luiz de Brito de Souza
    • Cristiane Araujo Martins Moreno

    Original Article 18 October 2023 Pages: 1225 - 1231

    

38. Rituximab as a sole steroid-sparing agent in generalized myasthenia gravis: Long-term outcomes

    • Zinovia-Maria Kefalopoulou
    • Dimitra Veltsista
    • Elisabeth Chroni

    Original Article 13 October 2023 Pages: 1233 - 1242

    

39. Eculizumab for myasthenic exacerbation during treatment with immune-checkpoint inhibitors

    • Laura Fionda
    • Elena Rossini
    • Giovanni Antonini

    Brief Communication 18 December 2023 Pages: 1243 - 1247

    

40. Posterior reversible encephalopathy syndrome and acute ischemic stroke: an underreported association

    • Marialuisa Zedde
    • Ilaria Grisendi
    • Rosario Pascarella

    Brief Communication 04 December 2023 Pages: 1249 - 1254

    

41. Neurofilament light chain as a biomarker in neuromyelitis optica spectrum disorder: a comprehensive review and integrated analysis with glial fibrillary acidic protein

    • Sohyeon Kim
    • Jae-Joon Lee
    • Hung Youl Seok

    Brief Communication 23 December 2023 Pages: 1255 - 1261

42. Acute disseminated encephalomyelitis following Saint Louis encephalitis virus infection

    • Denison Alves Pedrosa
    • Lucyana Karla Lima de Paula Oliveira
    • Rodrigo B. Thomaz

    Brief Communication 04 January 2024 Pages: 1263 - 1266

    

43. Iatrogenic Shapiro syndrome: a case report

    • Rosa Ferrer Tarrés
    • Marina Garcia Huguet
    • Gary Álvarez-Bravo

    Brief Communication 28 December 2023 Pages: 1267 - 1270

    

44. 40 Hz sensory entrainment: Is real-time EEG a good indicator of future cognitive improvement?

    • Prangya Parimita Sahu
    • Yu-Hui Lo
    • Philip Tseng

    Letter to the Editor 31 October 2023 Pages: 1271 - 1274

    

45. Dynamic diffusion imaging changes and unique midbrain involvement in a probable MV2K sCJD

    • Zhongyun Chen
    • Yu Kong
    • Liyong Wu

    Letter to the Editor 26 October 2023 Pages: 1275 - 1277

    

46. Parkinsonism with prominent neuropsychiatric symptoms without pyramidal involvement in a patient with FBXO7 variants

    • Surbhi Mahajan
    • Shivangi Mehta
    • Vivek Lal

    Letter to the Editor 17 October 2023 Pages: 1279 - 1281

    

47. Autosomal recessive spino-cerebellar ataxia type 10 (SCAR10): clinical presentation associated with c.289delA ANO10 gene variant

    • Davide Norata
    • Paolo Alonge
    • Vincenzo Di Stefano

    Letter to the Editor 19 October 2023 Pages: 1283 - 1286

    

48. No causal link between age at menopause and multiple sclerosis onset and severity: a Mendelian randomization study

    • Dongren Sun
    • Liangdan Tu
    • Hongyu Zhou

    Letter to the Editor 25 October 2023 Pages: 1287 - 1290

    

49. Letter to the Editor: a case of autoimmune glial fibrillary acidic protein astrocytopathy with acute paralytic ileus as initial symptom

    • Jianing Wang
    • Chaogang Tang
    • Shijian Luo

    Letter to the Editor 13 November 2023 Pages: 1291 - 1293

    

50. Isolated pontocerebellar leukoencephalopathy in HIV-related PML: focus on the “shrimp sign”

    • Angelo Tiziano Cimmino
    • Vincenzo Carlomagno
    • Gabriella Silvestri

    Letter to the Editor 23 October 2023 Pages: 1295 - 1298